Literature DB >> 2198527

Elevated c-myc expression in childhood medulloblastomas.

D N MacGregor1, E B Ziff.   

Abstract

Medulloblastoma is a rare brain tumor usually occurring in late childhood or early adolescence. Little is known regarding the cell of origin or cellular events leading to its malignant transformation. We have studied the expression of developmentally regulated mRNA in tumor samples by the Northern hybridization assay to determine a relative stage at which a block to further differentiation occurs. In a series of five medulloblastoma tumors analyzed, only one of eight markers for cellular differentiation, the glial fibrillary acidic protein mRNA, was expressed at significant levels. Interestingly, three of six medulloblastoma tumor samples were found to have elevated levels of c-myc mRNA. In one of these tumors, we have found evidence of mutation of the c-myc protooncogene. We discuss possible mechanisms of c-myc activation in medulloblastoma tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198527     DOI: 10.1203/00006450-199007000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Kinetic analysis of the interaction of b/HLH/Z transcription factors Myc, Max, and Mad with cognate DNA.

Authors:  Ozgur Ecevit; Mateen A Khan; Dixie J Goss
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

2.  Recurrent anaplastic ependymoma with an abnormal karyotype and c-myc proto-oncogene overexpression.

Authors:  M Debiec-Rychter; J Lasota; J Alwasiak; P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density.

Authors:  R Miralbell; M Tolnay; S Bieri; A Probst; A P Sappino; W Berchtold; M S Pepper; G Pizzolato
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins.

Authors:  W Scheurlen; N Sörensen; W Roggendorf; J Kühl
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

5.  A polymorphic variant of human c-Myc: Asn11-->Ser.

Authors:  P G Rothberg; Y M Otto
Journal:  Mamm Genome       Date:  1995-03       Impact factor: 2.957

Review 6.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

7.  c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.

Authors:  Alice Wey; Paul S Knoepfler
Journal:  Oncotarget       Date:  2010-06

8.  Evaluation of microsatellite instability in tumors of central nervous system: A pilot study.

Authors:  Minal Vaish; Raj Kumar; R D Mittal; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2004-07

9.  c- and N-myc regulate neural precursor cell fate, cell cycle, and metabolism to direct cerebellar development.

Authors:  Alice Wey; Veronica Martinez Cerdeno; David Pleasure; Paul S Knoepfler
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

10.  p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.

Authors:  E Jaros; J Lunec; R H Perry; P J Kelly; A D Pearson
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.